- Marketwired•2 years ago
Alchemia Limited, a drug discovery and development company, today announced the departure of Thomas Liquard as Chief Executive Officer.
- Marketwired•2 years agoAlchemia Announces Database Lock of Its HA-Irinotecan Pivotal Phase III Trial in Metastatic Colorectal Cancer
- Marketwired•3 years ago
Alchemia Limited , a drug discovery and development company, announced today the appointment of Ms. Jenni Pilcher as its Chief Financial Officer . Ms. Pilcher brings extensive financial leadership experience ...
ACL.AX : Summary for ALCHEMIA FPO - Yahoo Finance
Alchemia Limited (ACL.AX)
ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
|Day's Range||0.01 - 0.01|
|52 Week Range||0.01 - 0.02|
|PE Ratio (TTM)||-13.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|